FARMACIA HOSPITALARIA
FarmaciaHospitalaria-retos2017
FarmaciaHospitalaria-retos2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Manejo seguro de Medicamentos Peligrosos en las organizaciones sanitarias <br />
BIBLIOGRAFÍA<br />
• (1) ASHP technical assistance bulletin on handling cytotoxic<br />
and hazardour drugs. Review. Am J Hosp Pharm<br />
1990; 47 (5):1033-49.<br />
• (2) Occupational Safety and Health Administration<br />
(OSHA) https://www.osha.gov/SLTC/hazardousdrugs/<br />
• (3) NIOSH [2004]. NIOSH alert: preventing occupational<br />
exposure to antineoplastic and other hazardous<br />
drugs in health care settings. U.S. Department of Health<br />
and Human Services, Public Health Service, Centers<br />
for Disease Control and Prevention, National Institute<br />
for Occupational Safety and Health, DHHS (NIOSH)<br />
Publication No. 2004-165. http://www.cdc.gov/niosh/<br />
docs/2004-165/pdfs/2004-165.pdf<br />
• (4) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings 2010 DHHS (NIOSH) Publication<br />
No. 2010-167 (September 2010).<br />
• (5) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings 2012 DHHS (NIOSH) Publication<br />
No. 2012-150 (June 2012).<br />
• (6) NIOSH List of Antineoplastic and Other Hazardous<br />
Drugs in Healthcare Settings, 2014. http://www.cdc.<br />
gov/niosh/docs/2014-138/pdfs/2014-138.pdf<br />
• (7) NIOSH 2016. List of Antineoplastic and Other<br />
Hazardous Drugs in Healthcare Settings. 2016. https://<br />
www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf<br />
• (8) Documento Técnico Medicamentos peligrosos.<br />
Medidas de prevención para su preparación y administración.<br />
Instituto Nacional de Seguridad e Higiene en el<br />
Trabajo (INSHT) del Ministerio de Empresa y Seguridad<br />
Social. Septiembre 2016.<br />
• (9) Falck K, et al. Mutagenicity in urine of nurses handling<br />
cytostatic drugs. Lancet. 1979 Jun 9;1 (8128):1250-1251.<br />
• (10) Nguyen TV, Theiss JC, Matney TS. Exposure of<br />
pharmacy personnel to mutagenic antineoplastic drugs.<br />
Cancer Res. 1982 Nov;42 (11):4792-4796.<br />
• (11) Harris CC. The carcinogenicity of anticancer drugs: a<br />
hazard in man. Cancer. 1976 Feb;37 (2 Suppl):1014-1023.<br />
• (12) Gallelli JF. Issues and risks associated with handling<br />
antineoplastic drugs. J Pharm Pract. 1991 Feb;IV (1):72-<br />
76.<br />
• (13) Centers for Disease Control and Prevention (CDC).<br />
Hazardous Drug Exposure in Healthcare. (Updated: Mar<br />
16, 2016.) Accessed Mar 18, 2016. http://www.cdc.gov/<br />
niosh/topics/hazdrug/<br />
• (14) Sessink PJ, et al. Cancer risk assessment for health<br />
care workers occupationally exposed to cyclophosphamide.<br />
Int Arch Occup Environ Health. 1995;67 (5):317-<br />
323.<br />
• (15) Zhao SF, et al. The effects of occupational exposure<br />
of female nurses to antineoplastic drugs on pregnancy<br />
outcome and embryonic development. Teratology.<br />
1996;53 (2):94.<br />
• (16) Xie J, et al. An epidemiological study of the effect<br />
of occupational exposure to antineoplastic drugs on<br />
reproductive outcomes in nurses. Chin J Ind Hyg Occup<br />
Dis. 2001 Apr;19:87-90.<br />
• (17) Sessink PJ, et al. Environmental contamination and<br />
assessment of exposure to antineoplastic agents by<br />
determination of cyclophosphamide in urine of exposed<br />
pharmacy technicians: is skin absorption an important<br />
exposure route? Arch Environ Health. 1994 May-Jun;49<br />
(3):165-169.<br />
• (18) Miller, SA, Dodd, M, Goodman, MS et al, Cancer<br />
chemotherapy: Guidelines and recommendations for<br />
nursing education and practice. Oncology Nursing Society,<br />
Pittsburgh; 1984.<br />
• (19) US Department of Labor. Office of Occupational<br />
Medicine: Occupational Safety and Health Administration:<br />
Work practice guidelines for personnel dealing<br />
with cytotoxic (antineoplastic) drugs. Publication No.<br />
8-1.1. 1986.<br />
• (20) ASHP Guidelines on Handling Hazardous Drugs.<br />
ASHP bulletin, 1990. https://www.ashp.org/doclibrary/<br />
bestpractices/prepgdlhazdrugs.aspx<br />
• (21) General Chapter Hazardous Drugs—Handling<br />
in Healthcare Settings. United States Pharmacopeia.<br />
USP 2016 http://www.usp.org/usp-nf/notices/general-chapter-hazardous-drugs-handling-healthcare-settings<br />
• (22) General Chapter Pharmaceutical Compounding-Sterile<br />
Preparations United States Pharmacopeia.<br />
http://www.usp.org/usp-nf/notices/general-chapter-797-proposed-revision<br />
• (23) General Chapter Pharmaceutical Compounding-<br />
Non sterile Preparations United States Pharmacopeia.<br />
http://www.usp.org/es/usp-nf/official-text/<br />
revision-bulletins/pharmaceutical-compounding-nonsterile-preparations<br />
• (24) Beatriz G García-Alcántara, Catalina Perelló Alomar,<br />
Elena Moreno Centeno, Pilar Modamio, Eduardo L Mariño,<br />
Olga Delgado Sánchez. Impacto de las nuevas recomendaciones<br />
de manipulación de Medicamentos Peligrosos<br />
en un Servicio de Farmacia. Farm Hosp (en prensa).<br />
claves de 2017 79
Change language